Home » High-Quality Health Information » Health Topics » Multiple Myeloma » Study: NCT01034553

| Print this page

• Home
• High-Quality
  Health Information
  • Health Topics
  • Health Resources
• Understanding Health Research
  • What is health research?
  • Is health research safe?
  • Is health research
    right for me?
• Health Research in Massachusetts
  • Search Ongoing Studies
  • Community-Engaged Research Projects
  • Community Health Centers

Title:	Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Status:	Recruiting participants
Conditions:	Refractory Multiple Myeloma
Interventions:	Drug: Aurora A kinase inhibitor MLN8237; Drug: bortezomib
Institutions:	Dana-Farber Cancer Institute
Health Topics:	Multiple Myeloma
View this study on ClinicalTrials.gov

Contact Information

---

© Community Connect to Research, 2012